SCHEMBL8908478

SCHEMBL8908478

Cc1nc2cc(CC=O)ccc2[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
HSP90AA1 P07900 1/20 0.41
ESR2 Q92731 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 6/20 0.38
HPGD P15428 5/20 0.38
POLB P06746 4/20 0.38
KDM4E B2RXH2 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 3/20 0.36
HSD17B10 Q99714 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
GLA P06280 2/20 0.35
USP2 O75604 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6119062 0.87 ALDH1A1 (0.53) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL889003 0.85 ALDH1A1 (0.40) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL12213873 0.82 ALDH1A1 (0.46) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL3265753 0.81 ALDH1A1 (0.44) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL889001 0.79 HSD17B10 (0.47) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL889039 0.79 ALDH1A1 (0.43) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL889012 0.79 ALDH1A1 (0.43) ALDH1A1HSP90AA1ESR2TDP1MAPT
SCHEMBL889019 0.79 GAA (0.43) ALDH1A1HSP90AA1ESR2TDP1MAPT
Hydrochloric Acid SCHEMBL11367769 0.78 ALDH1A1 (0.46) ALDH1A1HSP90AA1ESR2TDP1MAPT
Hydrochloric Acid SCHEMBL11366200 0.78 HSD17B10 (0.46) ALDH1A1HSP90AA1ESR2TDP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188132-B2 Linked dibenzimidazole derivatives ENANTA PHARMACEUTICALS, INC. (US) 2012-05-29 US disclosed
US-20100221214-A1 LINKED DIBENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221214-A1 LINKED DIBENZIMIDAZOLE DERIVATIVES EIF2AK2, NSUN2, ZC3HAV1 ALDH1A1 287/4885HSP90AA1 2189/4885ESR2 2785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.